hepatitis C

AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAKwithout Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis
Yahoo
Mon, 04/25/16 - 06:39 pm
AbbVie
FDA
Viekira Pak
hepatitis C
New analysis boosts cost-effectiveness argument for Merck's Zepatier
BioPharma Dive
Wed, 04/20/16 - 06:37 pm
Merck
Zepatier
hepatitis C
Harvoni
Gilead Sciences
Merck's 'no patient left behind' approach to hepatitis C
BioPharma Dive
Mon, 04/18/16 - 09:00 pm
Merck
hepatitis C
Zepatier
Gilead Sciences
Sovaldi
Harvoni
AbbVie's experimental hep c combo proves highly effective across genotypes
BioPharma Dive
Mon, 04/18/16 - 04:27 pm
AbbVie
hepatitis C
ABT-493
ABT-530
This is the most expensive drug in America
Marketwatch
Thu, 04/14/16 - 09:22 pm
Gilead Sciences
Sovaldi
drug pricing
hepatitis C
Merck’s ZEPATIER™ (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial
Yahoo
Thu, 04/14/16 - 09:41 am
Merck
Zepatier
elbasvir/grazoprevir
hepatitis C
Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill
Motley Fool
Mon, 04/4/16 - 07:59 am
patents
hepatitis C
Medivation
Xtandi
Merck
Ionis Pharmaceuticals
Gilead Sciences
How Big of a Deal Are Gilead Sciences Patent Woes?
Motley Fool
Fri, 04/1/16 - 10:04 pm
Gilead Sciences
patents
Merck
Ionis Pharmaceuticals
hepatitis C
Gilead Sciences: ‘Another Pretender to Hepatitis C Throne Seems to Be Suffering the AbbVie Fate’
Barron's
Mon, 03/28/16 - 11:32 am
Gilead Sciences
hepatitis C
Merck
Zepatier
Harvoni
Patent Payoff? Merck's and Ionis Pharmaceuticals' Take Could Be Tiny
Motley Fool
Sat, 03/26/16 - 01:04 pm
Merck
Gilead Sciences
Ionis Pharmaceuticals
hepatitis C
patents
Harvoni
Sovaldi
Gilead to Pay Merck $200 Million in Damages Over Hepatitis C Drug Patents
WSJ Online
Fri, 03/25/16 - 09:42 am
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
Merck
Gilead has taken a lot of hits lately. Here’s what it really has to fear
Stat
Thu, 03/24/16 - 04:35 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Impact Of Merck Litigation On Ionis Pharmaceuticals
Seeking Alpha
Thu, 03/24/16 - 09:47 am
Ionis Pharmaceuticals
Merck
Gilead Sciences
patents
hepatitis C
Gilead's CEO: We are appealing the case
CNBC
Thu, 03/24/16 - 09:29 am
Gilead Sciences
patents
Merck
John Milligan
Harvoni
Sovaldi
hepatitis C
Gilead May Have to Pay Rival Merck Billions in Royalties
Fortune
Wed, 03/23/16 - 04:04 pm
Gilead Sciences
Merck
patents
sofosbuvir
Harvoni
Sovaldi
hepatitis C
Merck wins major victory in hep C patent case against Gilead
BioPharma Dive
Wed, 03/23/16 - 09:45 am
Merck
hepatitis C
patents
Gilead Sciences
sofosbuvir
Harvoni
Sovaldi
Gilead And The $3 Billion Merck Issue
Seeking Alpha
Fri, 03/18/16 - 11:10 am
Gilead Sciences
Merck
patents
hepatitis C
Harvoni
Sovaldi
Good news, hep C drugmakers: VA stops rationing your pricey treatments
Fierce Pharma Marketing
Wed, 03/16/16 - 07:19 pm
hepatitis C
Veterans Administration
VA to stop restricting hep C drugs, offering them to all infected veterans
Fierce Pharma
Sun, 03/13/16 - 01:13 pm
Veterans Administration
hepatitis C
Gilead Sciences
AbbVie
Gilead (GILD) Stock Gains, Owns 94% of Hepatitis-C Market
TheStreet.com
Sat, 03/12/16 - 09:39 am
Gilead Sciences
Harvoni
Sovaldi
hepatitis C

Pages